The latest buzz in the medical world is the use of GLP-1 agonists, specifically for weight loss. Why the hype? Well, for the first time in my career, there is a medication for weight loss that has some decent data and results behind it.
It is important when contemplating pharmaceutical interventions for weight loss to keep in mind it’s not “one size fits all.” Because everyone is different and will respond to interventions differently, treatment should truly be personalized and combine different modalities. This article will address the hungry brain phenotype outlined in some of the research on precision obesity treatment.
The decision to start pharmaceutical interventions for weight loss is never a light decision. Luckily there are clues to help figure out what is the best intervention. This is truly not “one size fits all.”
